Barings LLC cut its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 36.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 74,807 shares of the company’s stock after selling 42,916 shares during the quarter. Barings LLC’s holdings in Corteva were worth $5,014,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of the stock. Drummond Knight Asset Management Pty Ltd bought a new stake in shares of Corteva during the fourth quarter worth $25,713,000. Alberta Investment Management Corp bought a new stake in shares of Corteva during the third quarter worth $5,018,000. Avior Wealth Management LLC raised its stake in shares of Corteva by 464.7% during the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares in the last quarter. HighTower Advisors LLC boosted its holdings in shares of Corteva by 8.6% in the third quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after purchasing an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension purchased a new stake in shares of Corteva in the fourth quarter valued at approximately $23,679,000. 81.54% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on CTVA shares. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Morgan Stanley lifted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft lifted their price objective on Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Finally, Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $88.81.
Corteva Stock Performance
Shares of NYSE:CTVA opened at $74.85 on Friday. The company has a market capitalization of $50.06 billion, a price-to-earnings ratio of 44.03, a price-to-earnings-growth ratio of 2.28 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm has a 50 day moving average of $80.54 and a 200 day moving average of $75.30.
Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s payout ratio is currently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
